What is the primary purpose of this Amended and Restated Credit Agreement?

The primary purpose is to provide Microchip Technology with an unsecured revolving loan facility of up to $2.75 billion for working capital and general corporate purposes, ensuring continued financial flexibility for operations and strategic initiatives.

What is the maturity date of the new credit facility?

The revolving loans under the Restated Credit Agreement can be borrowed, repaid, and reborrowed until December 16, 2026, at which point all outstanding loans and accrued interest must be repaid.

Does this agreement involve any new debt or changes to Microchip's existing debt structure?

This agreement amends and restates an existing credit agreement, effectively updating the terms and potentially the amount available under its revolving credit facility. As of the filing date, approximately $1.826 billion in revolving loans and $7.4 million in letters of credit were outstanding under the new agreement, which supersedes the previous one.

What are the implications of the financial covenants and events of default mentioned?

The financial covenants require Microchip to maintain a maximum total leverage ratio and a consolidated minimum interest coverage ratio. Customary events of default are also included, such as non-payment, covenant breaches, and bankruptcy. The occurrence of an event of default could lead to the acceleration of all obligations under the credit agreement, potentially impacting the company's liquidity.

MCHP/MCHPP 8-K: Material Agreements & Financial Events

Summary

Microchip Technology Incorporated (MCHP) announced on December 16, 2021, the entry into an Amended and Restated Credit Agreement. This agreement amends and restates their previous credit facility, providing a significant unsecured revolving loan facility of up to $2.75 billion. This facility is intended for general corporate purposes and working capital, indicating the company's ongoing need for flexible financing to support its operations and growth strategies. The updated credit agreement extends the maturity date to December 16, 2026, and offers various interest rate options, including SOFR and EURIBOR-based rates, with spreads tied to the company's credit ratings. The agreement also allows for potential incremental term loans or revolving commitment increases up to $750 million, subject to lender commitments and financial covenant compliance. This demonstrates Microchip's proactive approach to capital management and its ability to access substantial credit markets.

Key Highlights

1Microchip Technology entered into an Amended and Restated Credit Agreement, enhancing its financing flexibility.
2The agreement establishes an unsecured revolving loan facility with a maximum principal amount of $2.75 billion.
3Proceeds from the facility are designated for working capital and general corporate purposes.
4The maturity date for the revolving loans is extended to December 16, 2026.
5Interest rates are variable, based on benchmarks like SOFR/SONIA/EURIBOR or a base rate, with spreads determined by credit ratings.
6The agreement allows for up to $750 million in incremental term loan facilities or revolving commitment increases.
7The facility includes customary covenants, financial maintenance requirements (leverage and interest coverage ratios), and events of default.

MICROCHIP TECHNOLOGY INC 8-K Report, Material Agreement (Dec 16, 2021)

Summary

Key Highlights

Frequently Asked Questions